by rss feed | Dec 18, 2024 | mesenchymal cells, Mesoblast, News Feeds, Remestemcel-l, RYONCIL
In a landmark decision, today the FDA approved Ryoncil from Mesoblast for GvHD. This is the first time the FDA has approved a mescenchymal stromal/stem cell or MSC therapy of any kind. There have been many ups and downs for Mesoblast toward this approval of Ryoncil or...
